David A. Siegel Nevro Corp Transaction History

Two Sigma Advisers, LP

$42.8 Billion
Q1 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Nevro Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 267,500 shares of NVRO stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

267,500

Previous 253,700 5.44%

Holding current value

$1.56 Million

Previous $943,000 65.64%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$3.29 - $5.85 $45,402 - $80,730	13,800 Added 5.44%	267,500 $1.56 Million
Q4 2024 Feb 14, 2025	SELL	$3.59 - $5.78 $112,008 - $180,336	-31,200 Reduced 10.95%	253,700 $943,000
Q3 2024 Nov 14, 2024	SELL	$4.71 - $10.1 $643,857 - $1.38 Million	-136,700 Reduced 32.42%	284,900 $1.59 Million
Q2 2024 Aug 14, 2024	SELL	$7.96 - $13.59 $641,576 - $1.1 Million	-80,600 Reduced 16.05%	421,600 $3.55 Million
Q1 2024 May 15, 2024	SELL	$13.56 - $20.78 $237,300 - $363,650	-17,500 Reduced 3.37%	502,200 $7.25 Million
Q4 2023 Feb 14, 2024	SELL	$14.18 - $22.31 $76,572 - $120,474	-5,400 Reduced 1.03%	519,700 $11.2 Million
Q3 2023 Nov 14, 2023	SELL	$18.22 - $25.85 $399,018 - $566,115	-21,900 Reduced 4.0%	525,100 $10.1 Million
Q2 2023 Aug 14, 2023	BUY	$22.62 - $39.32 $257,868 - $448,248	11,400 Added 2.13%	547,000 $13.9 Million
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $5.2 Million - $7.09 Million	172,400 Added 47.47%	535,600 $19.4 Million
Q4 2022 Feb 14, 2023	SELL	$36.43 - $49.4 $240,438 - $326,040	-6,600 Reduced 1.78%	363,200 $14.4 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $2.07 Million - $2.7 Million	51,000 Added 16.0%	369,800 $17.2 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $3.22 Million - $6.13 Million	78,900 Added 32.89%	318,800 $14 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $6.24 Million - $9.58 Million	104,100 Added 76.66%	239,900 $17.4 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $11 Million - $16.5 Million	135,800 New	135,800 $11 Million
Q2 2021 Aug 16, 2021	SELL	$141.6 - $179.06 $13.8 Million - $17.5 Million	-97,700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $5.07 Million - $6.96 Million	-38,200 Reduced 28.11%	97,700 $13.6 Million
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $4.81 Million - $6.42 Million	-34,800 Reduced 20.39%	135,900 $23.5 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $7.01 Million - $8.93 Million	-61,400 Reduced 26.45%	170,700 $23.8 Million
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $2.09 Million - $3.04 Million	-23,400 Reduced 9.16%	232,100 $27.7 Million
Q1 2020 May 15, 2020	BUY	$70.23 - $144.31 $7.21 Million - $14.8 Million	102,600 Added 67.1%	255,500 $25.5 Million
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $11.7 Million - $18 Million	152,900 New	152,900 $18 Million

Others Institutions Holding NVRO

# of Institutions

145

Shares Held

35.6M

Call Options Held

208K

Put Options Held

421K

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $207M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account